The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 07, 2026
Filed:
Oct. 14, 2021
Applicant:
Bausch + Lomb Ireland Limited, Dublin, IE;
Inventors:
Patrick Mccormick, Rochester, NY (US);
Kimberly Millard, Rochester, NY (US);
Assignee:
Bausch + Lomb Ireland Limited, Dublin, IE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/14 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/4402 (2006.01); A61K 31/498 (2006.01); A61K 31/55 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/14 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/4402 (2013.01); A61K 31/498 (2013.01); A61K 31/55 (2013.01); A61P 31/14 (2018.01);
Abstract
Methods for treating coronavirus disease 2019 (COVID-19), including at least one ocular manifestation of COVID-19, methods for treating conjunctivitis, and methods for reducing COVID-19 transmission comprising administering an effective amount of benzalkonium chloride are disclosed. Pharmaceutical compositions comprising benzalkonium chloride are also disclosed.
Mccormick, Patrick. (2026). Benzalkonium chloride foruse in treating conjunctivitis and/or covid-19 (U.S. Patent No. 12594251). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12594251
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile